This special issue is dedicated to theranostic studies including original research articles and review articles, which integrate specialized diagnosis and therapy using the various theranostic probes with an emphasis on cancer research. The new term "theranostics" was coined by combining two words: therapeutic and diagnostic. More specifically, therapeutic strategies including photodynamics, chemotherapy, gene therapy, hyperthermia, and radiation are integrated with one or more diagnostic imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), position emission tomography (PET), single photon emission computed tomography (SPECT), near-infrared (NIR) fluorescence imaging, and ultrasonography to develop molecular diagnostic tests and targeted therapeutics in clinics, resulting in the advance of personalized medicine. Therefore, these cutting-edge technologies allow us to simultaneously diagnose, image, and treat cancer and monitor the response of cancer treatment.
In this special issue, we invited colleagues worldwide who have been exploring cancer research for years, to discuss and report cutting-edge research in the use of nanomaterials for theranostics applications.
In one of the articles, Y.-Y. Ma et al. evaluate the potential of theranostic nanoparticles as a nanoplatform to load targeted molecules for both imaging and therapeutics. They also discuss the contributions of modern nanoparticles to accurate tumor image and effective tumor treatment. In summary, the six papers for this special issue containing 2 review articles and 4 original research reports, which were selected after peer-review by the guest editors Fu Wang, Lei Zhu, Kai Wang, and Dongkyoo Park, illustrate the broad scope of achievements and contributions of theranostics in the field of cancer research although all aspects of theranostics cannot be covered in one special issue.
